-
1 Comment
Zhejiang Yatai Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 17.5% above its 200 day moving average.
From a valuation standpoint, the stock is 57.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
Zhejiang Yatai Pharmaceutical Co., Ltd's total revenue rose by 1076.5% to $154M since the same quarter in the previous year.
Its net income has increased by 106.5% to $134M since the same quarter in the previous year.
Finally, its free cash flow grew by 61.9% to $-7M since the same quarter in the previous year.
Based on the above factors, Zhejiang Yatai Pharmaceutical Co., Ltd gets an overall score of 5/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100000MM5 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.28 |
|---|---|
| Target Price | 21.18 |
| Market Cap | 2B |
| PE Ratio | 78.25 |
| Dividend Yield | None |
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002370.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
